Engaging With FDA's New Complete Response Letter Policy
An April 20 citizen petition filed with the U.S. Food and Drug Administration has put renewed focus on the agency's new practice of releasing complete response letters, or CRLs, in near...To view the full article, register now.
Already a subscriber? Click here to view full article